KCRS25 Leadership Committee
TONI CHOUEIRI, MD
COMMITTEE CO-CHAIR
Dana-Farber Cancer Institute
HANS HAMMERS, MD, PhD
COMMITTEE CO-CHAIR
UT Southwestern Medical Center
ARI HAKIMI, MD, PhD
Memorial Sloan Kettering Cancer Center
RANA MCKAY, MD
University of California, San Diego
SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
THOMAS POWLES, MBBS, MRCP, MD
Barts Cancer Institute
BRYAN LEWIS
KidneyCAN CEO
SUSAN POTEAT
KidneyCAN Medical Science Liaison
LAURENCE ALBIGES, MD, PhD
Institut Gustave Roussy
KELLY FITZGERALD, MD
University of California, San Francisco
YASSER GED, MBBS
Johns Hopkins University
RANA MCKAY, MD
University of California, San Diego
JAIME MERCHAN, MD
University of Miami
JASON MUHITCH, PhD
Roswell Park Comprehensive Cancer Center
SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
WESLEY YIP, MD
City of Hope Comprehensive Cancer Center
CRISTIANE BERGEROT, PhD
City of Hope Comprehensive Cancer Center
DAVID BRAUN, MD, PhD
Yale School of Medicine
NAZLI DIZMAN, MD
MD Anderson Cancer Center
GIL MORGAN, MD
Skane University Hospital
PAVLOS MSAOUEL, MD, PhD
MD Anderson Cancer Center
RENEE MARIA SALIBY, MD
Dana-Farber Cancer Institute
MICHAEL SERZAN, MD
Dana-Farber Cancer Institute
YUKSEL URUN, MD
Ankara University School of Medicine
QING ZHANG, PhD
UT Southwestern Medical Center
ADRIAN HAYES
KidneyCAN Communications
pre-meeting
Variant Kidney Cancers: Bridging Biology to Breakthroughs
RANA MCKAY, MD
University of California, San Diego
ARI HAKIMI, MD, PhD
Memorial Sloan Kettering Cancer Center
speakers
YINGBEI CHEN, MD, PhD
Memorial Sloan Kettering Cancer Center
ELIZABETH HENSKE, MD
Brigham and Women’s Hospital/Harvard Medical School
JOSHUA MANN, MPH
VHL Alliance
SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
BRADLEY McGREGOR, MD
Dana-Farber Cancer Institute
VIVEK SUBBIAH, MD
Sarah Cannon Research Institute
SRINIVAS VISWANATHAN, MD, PhD
Dana-Farber Cancer Institute
CHANA WEINSTOCK, MD
U.S. Food and Drug Administration
WANLING XIE, MS
Dana-Farber Cancer Institute
kcrs25 day one
Keynote Speaker
W. KIMRYN RATHMELL
The Ohio State University Comprehensive Cancer Center
session 1
From Federal Funding to Patient Impact: Kidney Cancer Research That Delivers
ERIC JONASCH, MD
MD Anderson Cancer Center
CHERYL WALKER, PhD
Baylor College of Medicine
speakers
DAVID BRAUN, MD, PhD
Yale School of Medicine
ERIC JONASCH, MD
MD Anderson Cancer Center
MEI KOH, PhD
University of Utah
WAYNE MARASCO, MD, PhD
Dana-Farber Cancer Institute
CHERYL WALKER, PhD
Baylor College of Medicine
WENXIN (VINCENT) XU, MD
Dana-Farber Cancer Institute
session 2
Charting the Next Frontier: Genetic Evaluation and Screening for Early Detection of Kidney Cancer
MODERATORS
MICHAEL SERZAN, MD
Dana-Farber Cancer Institute
SAMANTHA GREENBERG
University of Texas Southwestern Medical Center
MARK BALL, MD, FACS
National Cancer Institute
LINDSEY BYRNE, MS, LGC
The Ohio State University Comprehensive Cancer Center
MARIA CARLO, MD
Memorial Sloan Kettering Cancer Center
GRANT STEWART, BSc, MBChB, PhD
University of Cambridge
session 3
Trials in Progress
MODERATORS
ROBERT MOTZER, MD
Memorial Sloan Kettering Cancer Center
THAI HO, MD, PhD
Medical University of South Carolina
SPEAKERS
Ritesh Kotecha, md
Memorial Sloan Kettering Cancer Center
NAZLI DIZMAN, MD
MD Anderson Cancer Center
BRADLEY McGREGOR, MD
Dana-Farber Cancer Institute
PRAFUL RAVI, MB, BChir, MRCP
Dana-Farber Cancer Institute
KARIE RUNCIE, MD
Columbia University Irving Medical Center
WENXIN (VINCENT) XU, MD
Dana-Farber Cancer Institute
International Neoadjuvant Kidney Cancer Consortium:
First Year Report
PROFESSOR AXEL BEX
Netherlands Cancer Institute
GRANT STEWART, BSc, MBChB, PhD
University of Cambridge
session 4
Rapid Oral Abstract Presentations
MODERATORS
SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
KELLY FITZGERALD, MD
University of California, San Francisco
speakers
RUCHI AGARWAL
University of Pennsylvania
YU-WEI CHEN, MD, MS
University of California, San Diego
CAROLINA ALVES COSTA SILVA
Institut Gustave Roussy
JAMES JONES, MD
University of Cambridge
THOMAS POWLES, MBBS, MRCP, MD
Barts Cancer Institute
KORAL SHAH, MD
City of Hope Comprehensive Cancer Center
CHAD TANG, MD
MD Anderson Cancer Center
DORIS ZHENG, BS, MBA
Memorial Sloan Kettering Cancer Center
MIGUEL ZUGMAN, MD
City of Hope Comprehensive Cancer Center
kcrs25 day two
session 5
Clinical and Scientific Updates in Kidney Cancer
TONI CHOUEIRI, MD
Dana-Farber Cancer Institute
MEHMET BILEN, MD
Emory Winship Cancer Institute
NAOMI HAAS, MD
Abramson Cancer Center
DAVID McDERMOTT, MD
Beth Israel Deaconess Medical Center
ROBERT MOTZER, MD
Memorial Sloan Kettering Cancer Center
THAI HO
Medical University of South Carolina
WENXIN (VINCENT) XU, MD
Dana-Farber Cancer Institute
session 6
From Concept to Clinic: The Emerging Role of Precision Immunotherapy in Kidney Cancer
HANS HAMMERS, MD, PhD
University of Texas Southwestern Medical Center
DAVID BRAUN, MD, PhD
Yale School of Medicine
SIDI CHEN, PhD
Yale University
CHARLES DRAKE, MD, PhD
Johnson & Johnson
PATRICK OTT, MD, PhD
Dana-Farber Cancer Institute
ROSA NADAL RIOS, MD, PhD
Fred Hutchinson Cancer Center
session 7
Oral Abstract Presentations
MODERATORS
RANA MCKAY, MD
University of California, San Diego
WESLEY YIP, MD
City of Hope Comprehensive Cancer Center
SPEAKERS
LAURENCE ALBIGES, MD, PhD
Institut Gustave Roussy
TONI CHOUEIRI, MD
Dana-Farber Cancer Institute
MARC MACHAALANI, MD
Dana-Farber Cancer Institute
QINQIN JIANG, PhD
Dana-Farber Cancer Institute
RANA MCKAY, MD
University of California, San Diego
BERKAY SIMSEK, MD
Brigham and Women’s Hospital
session 8
Biotech Showcase
MODERATORS
THOMAS POWLES, MBBS, MRCP, MD
Barts Cancer Institute
DAVID McDERMOTT, MD
Beth Israel Deaconess Medical Center
SPEAKERS
ROBERT AWADALLAH, PharmD, ANP, RPh, MBA
ITM Isotope Technologies
RANDI ISAACS, MD
Werewolf Therapeutics
BRIAN LIU, PhD
Caris Life Sciences
MINETTA LIU, MD
Natera
JONATHAN POWELL, MD, PhD
Calico Labs
JABED SERAJ
Kura Oncology
JONATHAN YINGLING, PhD
Arcus Biosciences
Thank You to the KCRS26 Partners & Sponsors
The Kidney Cancer Research Summit is funded through contributions from both grassroots donors and industry partners. We thank the generous partners and sponsors who support us in our mission to accelerate cures for kidney cancer.
Founding Partner
Sustaining Partners
Research Sponsors
Community Sponsors
Friends of KidneyCAN
